These results provide clues to neural mechanisms that support the development of GLP- 1 and GIP combination therapeutics for the treatment of obesity and DM [79]
The point is that MOTS-c's safety profile is harder to predict from first principles, and the data needed to narrow that uncertainty do not yet exist
Clinical Applications Reduces Appetite and Food Cravings Supports Long-Term Weight Management Stimulates Natural GLP-1, CCK and PYY Release Complements Lifestyle and Pharmaceutical Weight Loss Strategies Enhances Adherence to Intermittent Fasting and Time-Restricted Eating Successful weight management is now a global health concern as more than 43% of adults are categorized as overweight or obese
Excessive ROS production under drought, salinity, heat, and UV stress damages proteins, membrane, and photosynthetic complexes while also serving as a signaling cue for metabolic reorganization (Sachdev et al., 2021)
Ensuring adequate protein intake and staying hydrated helps maintain energy